Showing 676 results

Filters Content type: News, Editors' picks Country: East Asia
HIV treatment

South Korea mulls combining HIV drugs with antivirals to combat MERS

Editor's pick
in-Pharma Technologist
22 June 2015
Access to healthcare

China rejects Gilead hepatitis C drug patent: advocacy group

Editor's pick
Reuters
19 June 2015
Circumcision

In Global Fight Against HIV, China’s Circumcision Device Makes the Cut

Editor's pick
Wall Street Journal
18 June 2015
Undetectable viral load & treatment as prevention

Chinese study sheds light on how well treatment may work as prevention in the real world

News
1 April 2015
Travel

Zambians living with HIV being sent back from China

Editor's pick
Lusaka Times
31 March 2015
Hepatitis C treatment

Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Sovaldi® (sofosbuvir) for the Treatment of Genotype 2 Chronic Hepatitis C

Editor's pick
Gilead press release
31 March 2015
Hepatitis C treatment

Bristol-Myers Squibb Co. Is Back in the Hepatitis C Race

Editor's pick
Motley Fool
18 March 2015
Drug-resistant TB

Access sought to tuberculosis drug from nutraceutical company

Editor's pick
Nature Medicine
5 February 2015
HIV prevention policy

Interview - Asia needs more cash, campaigns, law changes to end HIV epidemic - U.N

Editor's pick
Reuters
29 January 2015
Travel

Taiwan drops ban on HIV-positive entrants

Editor's pick
Taipei Times
21 January 2015
Epidemiology & behaviour

China reports sharp rise in HIV cases in 2014

Editor's pick
Financial Times (free registration required)
19 January 2015
Hepatitis B

Experimental siRNA therapy lowers HBsAg levels in people with hepatitis B

News
6 January 2015
Health monitoring in resource-limited settings

Issue Brief: Achieving undetectable: what questions remain in scaling-up HIV virologic treatment monitoring?

Editor's pick
MSF
15 December 2014
Resistance

Drug-resistant infections could lead to 10 million extra deaths a year – report

Editor's pick
The Guardian
11 December 2014
HIV testing programmes & uptake

Reaching gay men: the next big test in HIV/Aids prevention in China

Editor's pick
South China Morning Post
3 December 2014
Access to healthcare

Gilead’s Proposed Hepatitis C Medicines License: How Badly Will it Miss the Target?

Editor's pick
Infojustice
17 September 2014
Hepatitis C treatment

Access to sofosbuvir in middle-income countries

Editor's pick
I-MAK
17 September 2014
The search for an HIV prevention vaccine

Novel immune-suppressant vaccine completely blocks HIV infection in monkeys: human trials planned

News
26 August 2014
Discrimination & the law

Passengers with HIV sue China's Spring Airlines

Editor's pick
BBC News
18 August 2014
Self-testing & home testing

Self-testing has the potential to boost HIV diagnosis rates among MSM in China

News
31 July 2014
New & experimental HIV treatments

The Medicines Patent Pool (MPP) broadens collaboration with Gilead Sciences: Signs licence for Phase III medicine tenofovir alafenamide (TAF)

Editor's pick
Medicines Patent Pool
25 July 2014
Discrimination & the law

In The HIV Response, Who is ‘Hard to Reach’?

Editor's pick
Human Rights Watch
23 July 2014
Harm reduction

Funding for HIV prevention for people who inject drugs is in crisis, experts warn

Editor's pick
The Observer
20 July 2014
New & experimental hepatitis C treatment

Japan Approves First All-Oral, Interferon- and Ribavirin-Free Hepatitis C Treatment, Daklinza® (daclatasvir) and Sunvepra® (asunaprevir) Dual Regimen

Editor's pick
Bristol-Myers Squibb press release
8 July 2014